SHARES OF NOVAVAX INCREASED ALMOST 20%

HIGHLIGHTS

• Small biotech firm Novavax has made progress in its efforts to develop a novel vaccine to guard against coronavirus disease.
• Phase I clinical testing will be conducted in May or June.
• Several biotechs and other drugmakers desperately trying to come up with a vaccine to treat the epidemic.

The company announced in a press release that it has made pro....